(Total Views: 546)
Posted On: 01/19/2021 1:30:26 PM
Post# of 154623
The answer is pretty simple. The protocol was designed when very little was known about COVID.
I dont believe the FDA would allow us to increase dosage, or change administration, as these things could affect the validity of the trial.
Once we show our data from this trial, they can begin to evaluate dosing procedures.
I dont believe the FDA would allow us to increase dosage, or change administration, as these things could affect the validity of the trial.
Once we show our data from this trial, they can begin to evaluate dosing procedures.
(5)
(0)
